Daniel E. Furst

Also affiliated with University of California, Los Angeles, Los Angeles City College, Scleroderma Foundation, University of Florence

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.526Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data

Arthritis Care & Research(2021)10.1002/acr.24785

Top 37%

0.526DataRank

Top 37%11 citations

Ashley Pinckney, Ellen Goldmuntz, Beverly Welch, Jennifer M. Franks, Viktor Martyanov +14 more

Papers

Driven by 21 papers — median percentile 63. Top paper: “Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease”.

Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis & Rheumatology(2021)10.1002/art.41668

N/A

5.5DataRank · unranked

194 citations

Celia J. F. Lin, Jonathan Goldin, Grace Hyun J. Kim, Daniel E. Furst, Christopher P. Denton +4 more

Machine learning predicts stem cell transplant response in severe scleroderma

Annals of the Rheumatic Diseases(2020)10.1136/annrheumdis-2020-217033

N/A

1.4DataRank · unranked

43 citations

Viktor Martyanov, Yue Wang, Tammara Wood, Ashley Pinckney, Leslie J. Crofford +9 more

Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30237-x

N/A

1.1DataRank · unranked

48 citations

Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton, Jerry A. Molitor +27 more

Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis

Arthritis & Rheumatology(2020)10.1002/art.41246

N/A

1.1DataRank · unranked

38 citations

Marco Matucci‐Cerinic, Daniel E. Furst, Masataka Kuwana, Yannick Allanore, Christopher P. Denton +8 more

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation

Annals of the Rheumatic Diseases(2023)10.1136/ard-2021-221926

N/A

0.795DataRank · unranked

22 citations

Michele Donato, Daniel E. Furst, Leslie J. Crofford, Ellen Goldmuntz, Lynette Keyes-Elstein +13 more

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy

Lara D. Veeken(2022)10.1093/rheumatology/keac015

N/A

0.607DataRank · unranked

10 citations

Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein, Paul K. Wallace +21 more

Systemic Sclerosis Mortality in the United States: 1979–1998

European Journal of Epidemiology(2005)10.1007/s10654-005-2210-5

N/A

0.604DataRank · unranked

55 citations

Daniel E. Furst, Eswar Krishnan

Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II

ACR Open Rheumatology(2020)10.1002/acr2.11125

N/A

0.604DataRank · unranked

55 citations

Donald P Tashkin, Holly LeClair, Michael D. Roth, Grace Hyun J. Kim, Jonathan Goldin +4 more

A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis

Arthritis & Rheumatology(2023)10.1002/art.42477

N/A

0.529DataRank · unranked

33 citations

Christopher P. Denton, Daniel E. Furst, Maureen D. Mayes, Marco Matucci‐Cerinic, Vanessa Smith +13 more

Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data

Arthritis Care & Research(2021)10.1002/acr.24785

Top 37%

0.526DataRank

Top 37%11 citations

Ashley Pinckney, Ellen Goldmuntz, Beverly Welch, Jennifer M. Franks, Viktor Martyanov +14 more

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study

Lara D. Veeken(2025)10.1093/rheumatology/keaf062

N/A

0.281DataRank · unranked

4 citations

Richard M. Silver, Virginia Steen, Daniel E. Furst, Flavia V. Castelino, Marcin A. Trojanowski +10 more

Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group

Seminars in Arthritis and Rheumatism(2021)10.1016/j.semarthrit.2020.09.023

N/A

0.269DataRank · unranked

5 citations

Niti Goel, Peter Tugwell, Dan Devoe, Paula R. Williamson, Caroline B. Terwee +14 more

Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study

Annals of the Rheumatic Diseases(2025)10.1136/ard-2024-226129

N/A

0.165DataRank · unranked

2 citations

Sabrina Mai Nielsen, Esben Malm, Daniel E. Furst, Josef S Smolen, Peter C. Taylor +7 more

Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group

Seminars in Arthritis and Rheumatism(2023)10.1016/j.semarthrit.2023.152288

N/A

0.165DataRank · unranked

2 citations

Lee S. Simon, Marieke Voshaar, Pam Richards, Niti Goel, Vibeke Strand +21 more

Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors

BMJ Open(2021)10.1136/bmjopen-2021-049850

N/A

0.104DataRank · unranked

1 citations

Sabrina Mai Nielsen, Johannes I. Berg, John P. A. Ioannidis, Josef S Smolen, Peter C. Taylor +6 more

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

Journal of Scleroderma and Related Disorders(2023)10.1177/23971983231163413

N/A

0DataRank · unranked

56 citations

Maya H Buch, Aleksandra Djoković, Giacomo De Luca, Raluca B Dumitru, Alessandro Giollo +30 more

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis

Annals of the Rheumatic Diseases(2022)10.1136/ard-2021-221925

N/A

0DataRank · unranked

14 citations

Amin Zia, Michelle S. Bloom, Leslie J. Crofford, Daniel E. Furst, Ellen Goldmuntz +10 more

Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis

Arthritis Research & Therapy(2021)10.1186/s13075-020-02383-w

N/A

0DataRank · unranked

34 citations

Steven K. Lundy, Michael L. Whitfield, Veronica J. Berrocal, Phillip L. Campbell, Stephanie Rasmussen +10 more

Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long‐Term Normalization of Systemic Sclerosis Molecular Signatures

Arthritis & Rheumatology(2024)10.1002/art.42847

N/A

0DataRank · unranked

6 citations

Xuan Wang, Lynette Keyes‐Elstein, Ellen Goldmuntz, Marka A. Lyons, Peter A. McSweeney +9 more

Large‐Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis

Arthritis & Rheumatology(2020)10.1002/art.41570

N/A

0DataRank · unranked

15 citations

Binwu Ying, Ellen Goldmuntz, Lynette Keyes‐Elstein, John Varga, Monique Hinchcliff +12 more

Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II

ACR Open Rheumatology(2020)10.1002/acr2.11206

N/A

0DataRank · unranked

14 citations

Virginia Steen, Ning Li, Michael D. Roth, Philip J. Clements, Daniel E. Furst +7 more

Daniel E. Furst

Indexed papers

Top data-sharing exemplar

Papers